APA

Cole D. J., Sanda M. G., Yang J. C., Schwartzentruber D. J., Weber J., Ettinghausen S. E., Pockaj B. A., Kim H. I., Levin R. D. & Pogrebniak H. W. (19940202). Phase I trial of recombinant human macrophage colony-stimulating factor administered by continuous intravenous infusion in patients with metastatic cancer. : Journal of the National Cancer Institute.

Chicago

Cole D J, Sanda M G, Yang J C, Schwartzentruber D J, Weber J, Ettinghausen S E, Pockaj B A, Kim H I, Levin R D and Pogrebniak H W. 19940202. Phase I trial of recombinant human macrophage colony-stimulating factor administered by continuous intravenous infusion in patients with metastatic cancer. : Journal of the National Cancer Institute.

Harvard

Cole D. J., Sanda M. G., Yang J. C., Schwartzentruber D. J., Weber J., Ettinghausen S. E., Pockaj B. A., Kim H. I., Levin R. D. and Pogrebniak H. W. (19940202). Phase I trial of recombinant human macrophage colony-stimulating factor administered by continuous intravenous infusion in patients with metastatic cancer. : Journal of the National Cancer Institute.

MLA

Cole D J, Sanda M G, Yang J C, Schwartzentruber D J, Weber J, Ettinghausen S E, Pockaj B A, Kim H I, Levin R D and Pogrebniak H W. Phase I trial of recombinant human macrophage colony-stimulating factor administered by continuous intravenous infusion in patients with metastatic cancer. : Journal of the National Cancer Institute. 19940202.